查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1885864

用于伤口癒合的蛋白质水解物市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Protein Hydrolysates for Wound Healing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球伤口癒合用蛋白质水解物市场价值为 8.925 亿美元，预计到 2034 年将以 12.1% 的复合年增长率增长至 28 亿美元。

用于伤口癒合的蛋白质水解物市场 - IMG1

市场扩张的驱动力在于人们对先进伤口护理技术的认知不断提高，以及全球慢性伤口盛行率的上升。源自胶原蛋白、角质蛋白和明胶的蛋白质水解物因其富含氨基酸和生物活性胜肽，在加速组织修復方面发挥关键作用。这些化合物有助于刺激组织再生、促进胶原蛋白形成并最大限度地减少炎症，最终促进伤口更快癒合并减少疤痕形成。它们良好的生物相容性使其非常适合用于伤口敷料、外用溶液和再生医学等医疗应用。糖尿病溃疡、压疮和术后伤口的发生率不断上升，持续推高市场需求，而全球人口老化也进一步强化了对有效伤口管理产品的需求。随着医疗保健机构寻求能够增强细胞活性和改善癒合环境的解决方案，预计市场将迎来创新和产品扩张的巨大机会。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 8.925亿美元
预测值 28亿美元
复合年增长率 12.1%

胶原蛋白水解物在2024年占据了45%的市场份额，这得益于其已证实的临床疗效、监管批准和广泛的适用性。这些产品来自多种途径，包括牛、猪、马、禽和海洋生物，其中动物源性产品目前仍占据最强的商业地位，儘管人们对海洋来源和重组配方的兴趣日益浓厚。

2024年，粉末状蛋白水解物市占率达到55.1%。其保质期长、浓度高、储存方便且用途广泛，使其在医疗领域备受青睐。粉末製剂采用酵素处理后，经冷冻干燥、喷雾干燥和真空干燥等製程生产，既方便临床医生和患者使用，又经济实惠。

2024年，北美伤口癒合用蛋白水解物市占率达到40.1%，预计到2034年将以12.3%的复合年增长率成长。该地区的成长得益于强大的医疗基础设施、慢性伤口病例的增加以及对创新伤口护理技术日益增长的需求。微创疗法的广泛接受和研发活动的持续发展，并不断推动相关技术的进步。对个人化护理和新一代伤口管理解决方案的持续关注，使北美成为全球市场扩张的重要贡献者。

全球伤口癒合用蛋白水解物市场的主要企业包括：菲仕兰坎皮纳（FrieslandCampina）、英格瑞亚（Ingredia SA）、美德瑞顿（Medtrition）、海美德（Hymed）、恆天然（Fonterra NZMP）、阿拉食品配料（Arla Foods Ingredients）、希尔玛米（恆天然（Discom） International）、纽崔福（Nutriform）、德玛瑞特（DermaRite）和格兰比亚（Glanbia plc）。参与伤口癒合用蛋白水解物市场竞争的企业正采取一系列策略来巩固其市场地位。许多企业正在扩大产能以满足不断增长的全球需求，同时推动水解技术的发展，以提高胜肽的纯度和治疗效果。与伤口护理产品製造商和医疗机构的策略合作有助于加速产品推广，并支持实证验证。此外，各企业也透过开发针对慢性伤口、手术恢復和再生疗法的专用配方来实现产品组合多元化。永续发展倡议，例如探索海洋和重组来源，有助于企业保持长期竞争力并符合监管要求。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
    • 供应商格局
    • 利润率
    • 每个阶段的价值增加
    • 影响价值链的因素
    • 中断
  • 产业影响因素
    • 成长驱动因素
    • 产业陷阱与挑战
    • 市场机会
  • 成长潜力分析
  • 监管环境
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特的分析
  • PESTEL 分析
  • 价格趋势
    • 按地区
    • 依产品类型
  • 未来市场趋势
  • 技术与创新格局
    • 当前技术趋势
    • 新兴技术
  • 专利格局
  • 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
    • 主要进口国
    • 主要出口国
  • 永续性和环境方面
    • 永续实践
    • 减少废弃物策略
    • 生产中的能源效率
    • 环保倡议
  • 碳足迹考量

第四章：竞争格局

  • 介绍
  • 公司市占率分析
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • MEA
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 合作伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依产品类型划分，2021-2034年

  • 主要趋势
  • 胶原蛋白水解物
    • 牛胶原蛋白水解物
    • 猪胶原蛋白水解物
    • 海洋胶原蛋白水解物
    • 禽类胶原蛋白水解物
  • 海洋蛋白水解物
    • 鱼源性生物活性胜肽
    • 贝类水解物
    • 藻类蛋白水解物
    • 水母胶原蛋白胜肽
  • 乳清蛋白水解物
  • 特製胺基酸配方
    • 富含精胺酸的水解物
    • 添加麸酰胺酸的配方
    • 支链胺基酸复合物

第六章：市场估算与预测：以实物形式划分，2021-2034年

  • 主要趋势
  • 粉末
  • 液体

第七章：市场估算与预测：依加工方式划分，2021-2034年

  • 主要趋势
  • 酵素水解
  • 酸水解
  • 碱性水解
  • 组合处理方法

第八章：市场估算与预测：依应用领域划分，2021-2034年

  • 关键趋势
  • 慢性伤口管理
    • 糖尿病足溃疡
    • 压疮/溃疡
    • 静脉性腿部溃疡
    • 动脉溃疡
  • 急性伤口护理
    • 手术伤口
    • 创伤性损伤
    • 烧伤治疗
    • 紧急伤口护理
  • 术后恢復
    • 骨科手术恢復
    • 心血管外科支持
    • 一般外科应用
    • 整形与重建外科
  • 预防性伤口护理
    • 高危险群患者营养支持
    • 术前准备
    • 免疫功能低下患者的护理
    • 老年人伤口预防

第九章：市场估计与预测：依地区划分，2021-2034年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第十章：公司简介

  • Arla Foods Ingredients
  • Davisco Foods International
  • DermaRite
  • Fonterra NZMP
  • FrieslandCampina
  • Glanbia plc
  • Hilmar Ingredients
  • Hymed
  • Ingredia SA
  • Medtrition
  • Nutriform
简介目录
Product Code: 15281

The Global Protein Hydrolysates for Wound Healing Market was valued at USD 892.5 million in 2024 and is estimated to grow at a CAGR of 12.1% to reach USD 2.8 billion by 2034.

Protein Hydrolysates for Wound Healing Market - IMG1

Market expansion is driven by increasing awareness of advanced wound care technologies and the rising prevalence of chronic wounds worldwide. Protein hydrolysates derived from collagen, keratin, and gelatin play a critical role in accelerating tissue repair due to their rich amino acid content and bioactive peptides. These compounds help stimulate tissue regeneration, support collagen formation, and minimize inflammation, ultimately promoting faster healing and reduced scarring. Their strong biocompatibility makes them well-suited for medical applications across wound dressings, topical solutions, and regenerative medicine. Growing incidences of diabetic ulcers, pressure injuries, and postoperative wounds continue to increase demand, while the aging global population further strengthens the need for effective wound management products. As healthcare providers pursue solutions that enhance cellular activity and improve healing environments, the market is expected to see significant opportunities for innovation and product expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$892.5 Million
Forecast Value$2.8 Billion
CAGR12.1%

The collagen hydrolysates segment held a 45% share in 2024, supported by proven clinical benefits, regulatory approvals, and broad applicability. These products originate from multiple sources, including bovine, porcine, equine, avian, and marine materials, with animal-based variants currently holding the strongest commercial position even as interest grows in alternative marine and recombinant formulations.

The powder-based protein hydrolysates segment held 55.1% share in 2024. Their long shelf life, high concentration, storage convenience, and versatile application make them appealing for medical settings. Produced through methods like freeze-drying, spray-drying, and vacuum-drying following enzymatic processing, powder formulations provide ease of use for clinicians and patients while remaining cost-effective.

North America Protein Hydrolysates for Wound Healing Market held 40.1% share in 2024 and is projected to grow at a 12.3% CAGR through 2034. Growth in the region is supported by strong healthcare infrastructure, rising cases of chronic wounds, and increasing demand for innovative wound care technologies. Greater acceptance of minimally invasive approaches and expanded research and development activity continue to drive advancements. Ongoing interest in personalized care and next-generation wound management solutions positions North America as a major contributor to global market expansion.

Key companies in the Global Protein Hydrolysates for Wound Healing Market include FrieslandCampina, Ingredia SA, Medtrition, Hymed, Fonterra NZMP, Arla Foods Ingredients, Hilmar Ingredients, Davisco Foods International, Nutriform, DermaRite, and Glanbia plc. Companies competing in the Protein Hydrolysates for Wound Healing Market are employing a range of strategies to strengthen their market position. Many are expanding production capabilities to meet rising global demand while advancing hydrolysis technologies to improve peptide purity and therapeutic effectiveness. Strategic collaborations with wound care manufacturers and healthcare institutions help accelerate product adoption and support evidence-based validation. Firms are also diversifying their portfolios by developing specialized formulations targeted at chronic wounds, surgical recovery, and regenerative therapies. Sustainability initiatives, such as exploring marine and recombinant sources, support long-term competitiveness and regulatory alignment.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product type
    • 2.2.3 Physical form
    • 2.2.4 Processing method
    • 2.2.5 Application
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product type
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 (USD Million & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Collagen hydrolysates
    • 5.2.1 Bovine collagen hydrolysates
    • 5.2.2 Porcine collagen hydrolysates
    • 5.2.3 Marine collagen hydrolysates
    • 5.2.4 Avian collagen hydrolysates
  • 5.3 Marine protein hydrolysates
    • 5.3.1 Fish-derived bioactive peptides
    • 5.3.2 Shellfish-derived hydrolysates
    • 5.3.3 Algae-based protein hydrolysates
    • 5.3.4 Jellyfish collagen peptides
  • 5.4 Whey protein hydrolysates
  • 5.5 Specialized amino acid formulations
    • 5.5.1 Arginine-enriched hydrolysates
    • 5.5.2 Glutamine-enhanced formulations
    • 5.5.3 Branched-chain amino acid complexes

Chapter 6 Market Estimates and Forecast, By Physical Form, 2021-2034 (USD Million & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder
  • 6.3 Liquid

Chapter 7 Market Estimates and Forecast, By Processing Method, 2021-2034 (USD Million & Kilo Tons)

  • 7.1 Key trends
  • 7.2 Enzymatic hydrolysis
  • 7.3 Acid hydrolysis
  • 7.4 Alkaline hydrolysis
  • 7.5 Combined processing methods

Chapter 8 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

  • 8.1 Key trend
  • 8.2 Chronic wound management
    • 8.2.1 Diabetic foot ulcers
    • 8.2.2 Pressure injuries/ulcers
    • 8.2.3 Venous leg ulcers
    • 8.2.4 Arterial ulcers
  • 8.3 Acute wound care
    • 8.3.1 Surgical wounds
    • 8.3.2 Traumatic injuries
    • 8.3.3 Burn treatment
    • 8.3.4 Emergency wound care
  • 8.4 Post-surgical recovery
    • 8.4.1 Orthopedic surgery recovery
    • 8.4.2 Cardiovascular surgery support
    • 8.4.3 General surgery applications
    • 8.4.4 Plastic & reconstructive surgery
  • 8.5 Preventive wound care
    • 8.5.1 High-risk patient nutritional support
    • 8.5.2 Pre-surgical conditioning
    • 8.5.3 Immunocompromised patient care
    • 8.5.4 Geriatric wound prevention

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Arla Foods Ingredients
  • 10.2 Davisco Foods International
  • 10.3 DermaRite
  • 10.4 Fonterra NZMP
  • 10.5 FrieslandCampina
  • 10.6 Glanbia plc
  • 10.7 Hilmar Ingredients
  • 10.8 Hymed
  • 10.9 Ingredia SA
  • 10.10 Medtrition
  • 10.11 Nutriform